补心气滋心阴口服液治疗肺心病急性发作期气阴两虚 型临床疗效观察_（During the period of Qi and yin deficiency type clinical curative effect observation of acute _ Buxinqi Zixinyin oral liquid in the treatment of pulmonary heart disease）.docVIP

补心气滋心阴口服液治疗肺心病急性发作期气阴两虚 型临床疗效观察_（During the period of Qi and yin deficiency type clinical curative effect observation of acute _ Buxinqi Zixinyin oral liquid in the treatment of pulmonary heart disease） To observe the clinical effect of acute attack period of Qi and yin deficiency type Buxinqi Zixinyin oral liquid in the treatment of pulmonary heart disease Update Date: 2010-11-17 Click: Li Suyun, Sun Lei We at 1994-12 ~ 1997-12, the application of Hubei Xianning pharmaceutical factory production of Buxinqi Zixinyin Decoction in Treating 98 cases of acute exacerbation of chronic pulmonary heart disease with deficiency of both qi and Yin, and achieved remarkable curative effect. The report is summarized as follows. 1 data and methods 1.1 clinical data: there are 128 inpatients with acute episode of chronic cor pulmonale in this group. Western medicine diagnosis and staging standards are in line with the second National Conference on pulmonary heart disease in 1997. The standard of TCM syndrome differentiation conforms to the standard of TCM Deficiency Syndrome diagnosis. 128 cases were randomly divided into treatment group and control group: the treatment group 98 cases, male 66 cases, female 32 cases, aged 45 to 76 years old, the average age is 66.46, the duration of 10 ~ 32a, average 19.45a, 60 cases of mild to moderate respiratory failure; the control group of 30 cases, male 16 cases, female 14 cases, age 49 to 80 years old, average 66.52 years old, the duration of 12 ~ 30a, average 20.7a, 19 cases of mild to moderate respiratory failure. There was no significant difference between the two groups in clinical data (P 0.05) 1.2, the content and methods of observation 1.2.1 blood gas analysis: the United States NOV2-5 blood gas electrolyte automatic analyzer was used to determine the peripheral arterial blood and PaO2 and PaCO2. 1.2.2 T lymphocyte subsets: T lymphocyte subsets, CD3, CD4, CD 8, CD4/CD8, were measured by APAAP technique. 1.2.3 lung function: use Nissa